Release Date: 31/08/12 14:47 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 157.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%